Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000939
Chunk: 14

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 14
---
 the thirty-six (36) month anniversary of the Commencement Date.

(aa) “”
means the period commencing at 9:30 a.m., Eastern time, on the fifth (5th) Business Day immediately prior to the filing of any post-effective
amendment to the Registration Statement (as defined herein) or New Registration Statement (as such term is defined in the Registration
Rights Agreement), and ending at 9:30 a.m., Eastern time, on the Business Day immediately following, the effective date of any post-effective
amendment to the Registration Statement (as defined herein) or New Registration Statement (as such term is defined in the Registration
Rights Agreement).

(bb) “” means any securities of the Company entitling the holder thereof to acquire at any time Ordinary Shares or
Depositary Shares, including, without limitation, any debt, preferred share, right, option, warrant or other instrument that is at any
time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Ordinary Shares or Depositary
Shares.

(cc) “”
means an individual or entity including but not limited to any limited liability company, a partnership, a joint venture, a corporation,
a trust, an unincorporated organization and a government or any department or agency thereof.

(dd) “” means The Nasdaq Capital Market (or any nationally recognized successor thereto); provided, however, that in the event
the Company’s Depositary Shares are not listed on The Nasdaq Capital Market (or any nationally recognized successor thereto) but
is then listed or traded on The Nasdaq Global Market, The Nasdaq Global Select Market, the New York Stock Exchange, the NYSE American,
the NYSE Arca, or the OTCQB or the OTCQX operated by OTC Markets Group, Inc. (or any nationally recognized successor to any of the foregoing),
then the “Principal Market” shall mean such other market or exchange on which the Company’s Depositary Shares are then
listed or traded.

| -5- |

(ee) “” means, with respect to any Fixed Purchase, any VWAP Purchase or any Additional VWAP Purchase made hereunder, as applicable,
the portion of the Available Amount to be purchased by the Investor pursuant to hereof.

(ff) “” means any date that is a Fixed Purchase Date, a VWAP Purchase Date and/or an Additional VWAP Purchase Date, as applicable.

(gg) “”
means any trade price for